Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$0.83 - $1.24 $44,727 - $66,821
-53,888 Reduced 81.42%
12,294 $11,000
Q4 2022

Feb 15, 2023

BUY
$0.77 - $1.62 $50,960 - $107,214
66,182 New
66,182 $53,000
Q2 2022

Aug 09, 2022

BUY
$1.65 - $3.13 $20,902 - $39,650
12,668 New
12,668 $32,000
Q3 2021

Nov 12, 2021

SELL
$5.9 - $7.44 $219,196 - $276,410
-37,152 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$5.78 - $9.6 $106,276 - $176,515
18,387 Added 97.99%
37,152 $250,000
Q1 2021

May 19, 2021

BUY
$5.67 - $12.54 $106,397 - $235,313
18,765 New
18,765 $137,000

Others Institutions Holding NHWK

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.